Company Filing History:
Years Active: 2003-2007
Title: Brian Donahue: Innovator in Cancer Treatment
Introduction
Brian Donahue is a notable inventor based in Los Altos, California. He has made significant contributions to the field of cancer treatment through his innovative approaches. With a total of 2 patents, Donahue's work focuses on advanced therapeutic methods that aim to improve patient outcomes.
Latest Patents
One of Donahue's latest patents is titled "Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes." This invention provides therapeutic compositions and methods for the vector-mediated delivery and in vivo expression of polynucleotides encoding anti-cancer compounds. The invention particularly emphasizes the use of recombinant viral and non-viral vectors to deliver genes that encode anti-angiogenic or pro-apoptotic gene products for effective cancer treatment. Another significant patent is "Use of suppressor tRNA's to regulate cytotoxicity during the production of recombinant gene products." This patent describes how suppressor tRNA's can be utilized to regulate the expression of transgenes that are toxic or require a toxic factor for expression in host cells.
Career Highlights
Brian Donahue is currently associated with Cell Genesys, Inc., where he continues to develop innovative solutions in the field of gene therapy. His work has been instrumental in advancing the understanding and treatment of cancer through genetic approaches.
Collaborations
Some of his notable coworkers include Thomas Harding and Karin Ute Jooss, who have collaborated with him on various projects aimed at enhancing cancer treatment methodologies.
Conclusion
Brian Donahue's contributions to cancer treatment through his innovative patents highlight his commitment to improving healthcare outcomes. His work at Cell Genesys, Inc. continues to pave the way for advancements in gene therapy.